• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Doug Kass
    • Bruce Kamich
    • Jim Cramer
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing

Mylan May Make Generics but Its Charts are Starting to Look 'Name Brand'

Let's check of the charts and indicators to see if this is a good time to approach the long side of MYL.
By BRUCE KAMICH
Nov 14, 2018 | 12:18 PM EST
Stocks quotes in this article: TEVA, MYL

When asked about generic drug maker Teva Pharmaceuticals (TEVA) during the fast paced "Lightning Round" on Tuesday night's "Mad Money" program, TheStreet's Jim Cramer said, "In that genre, we like Mylan N.V. (MYL) more."

A recommendation from Jim Cramer of MYL is a good place to start but let's do a quick check of the charts and indicators to see if this is a good time to approach the long side of MYL.

In this daily bar chart of MYL, below, we can see a downtrend from January to October but this could be a different story on the weekly chart. Prices are below the declining 50-day moving average line and rallies from August have all stopped short of the bearish 200-day moving average line.

The daily On-Balance-Volume (OBV) line shows what I think is a very bullish pattern. Over the past 12 months the OBV has risen even though the price of MYL has declined. A rising OBV line when a stock is falling suggests to me that buyers of MYL have been scale-down buyers.

The Moving Average Convergence Divergence (MACD) oscillator just crossed to the upside of the zero line for an outright go long signal.

In this weekly bar chart of MYL, below, we can view the price action at least two ways.

One way is too see a downtrend over the past three years but prices have not made a new low since late 2017.

Another way to look at this chart is to imagine a double bottom pattern of sorts. We have a low in August of 2017 and another low in October of 2018. This large reversal pattern will not be complete until a rally above $48, but if we wait for that to happen we will miss most of the move. Prices are below the flat 40-week moving average line but a close above $38 would break the line.

The weekly OBV line has made a low in October which is just slightly higher than the September low of 2017.

The weekly MACD oscillator is ready to cross to the upside for a cover shorts buy signal.

In this weekly Point and Figure chart of MYL, below, we can see a long-term price target of $50.92. Strength above $39.78 is needed to turn this chart more bullish.

Bottom line strategy: MYL may try to fill the upside price gap made earlier this month. Traders could consider buying that possible weakness risking a close below $30. Traders who prefer to buy strength could go long above $38 will be risking below $35.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Employees of TheStreet are restricted from trading individual securities.

TAGS: Investing

More from Investing

As Nike Finds Its Footing on Direct Sales, Expect It to Race Higher in 2020

Stephen Guilfoyle
Dec 5, 2019 11:39 AM EST

But if China trade talks fail, this shoe company could get tripped up, so here's how to play it.

Ready, Set, Go: Nike Could Break Out to the Upside

Bruce Kamich
Dec 5, 2019 11:09 AM EST

Let's check the charts and technical indicators before we lace up a recommendation.

Weakness After Protracted Upside Move Causes Discomfort

James "Rev Shark" DePorre
Dec 5, 2019 10:52 AM EST

Some traders seem unsettled by a bit of downside volatility after not experiencing much of it of late.

Here's How I'd Play Nike

Timothy Collins
Dec 5, 2019 10:41 AM EST

Nike is a name that draws a good amount of business from China.

Avita Medical Could Double in 2020 but Not Without Risk

Bruce Kamich
Dec 5, 2019 9:53 AM EST

A 'promising' stock.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 12:24 PM EST GARY BERMAN

    Fibocall: The SPX-Cash Long-Term View

    You will hear from many analysts on TV screaming t...
  • 10:35 AM EST BOB LANG

    Added Some Apple

    We'll take advantage of this pullback and add some...
  • 01:50 PM EST BOB LANG

    Added Some HD, MRTX

    We'll add this strong biotech name and a retailer ...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2019 TheStreet, Inc., 14 Wall Street, 15th Fl, NY, NY 10005

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login